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NOVELTY STATEMENTDiabetes screening strategies using glycated haemoglobin (HbA1c) as first‐instance diagnostic parameter may cause failure to detect individuals with abnormal glucose regulation and possible signs of microvascular complications despite "rule‐out" HbA1c levels.Based on population‐based cross‐sectional data from 2695 individuals without prior diagnosis of diabetes, we found that individuals with normal HbA1c but prediabetic or diabetic levels of fasting and/or two‐hour postload plasma glucose had a significantly higher prevalence of moderately increased albuminuria than individuals with normal HbA1c and normal fasting and two‐hour postload plasma glucose levels.Age, gender and BMI may help to better identify this at‐risk group, which otherwise would escape detection and early intervention.

1. INTRODUCTION {#edm230-sec-0006}
===============

Over the past decades, the prevalence of type 2 diabetes has increased worldwide to a pandemic scale. It has been estimated that the number of individuals with yet undiagnosed diabetes was as high as 193 million in 2015 and is expected to increase further by 2040 to 642 million people with diabetes and 481 million people with prediabetes.[1](#edm230-bib-0001){ref-type="ref"} Diabetes constitutes a major challenge for public healthcare systems as untreated hyperglycaemia can result in micro‐ and macrovascular complications such as diabetic retinopathy, chronic kidney failure, diabetic polyneuropathy or coronary artery disease and stroke.[2](#edm230-bib-0002){ref-type="ref"} One early sign of diabetic complications is moderately increased albuminuria. It is an indicator of chronic kidney damage and it is correlated with the risk of cardiovascular events.[3](#edm230-bib-0003){ref-type="ref"} To prevent the development or progression of such complications, early detection of individuals with yet unrecognized prediabetes and diabetes is of importance. The traditionally established measurements of fasting plasma glucose (FPG) and the oral glucose tolerance test (OGTT) have major drawbacks such as need for compliance to 8‐hour fasting and large intraindividual variability.[4](#edm230-bib-0004){ref-type="ref"}, [5](#edm230-bib-0005){ref-type="ref"} In the current position statement of the American Diabetes Association (ADA) and in the statement of the European Association for the Study of Diabetes (EASD), it is recommended to use glycated haemoglobin HbA1c as the preferred diagnostic tool for diabetes screening to overcome these limitations.[6](#edm230-bib-0006){ref-type="ref"}, [7](#edm230-bib-0007){ref-type="ref"} Some guidelines, including those of the German Diabetes Association, recommend a stepwise diagnostic approach using HbA1c as a first screening test with two different cut‐off values for the diagnostic decision, of which the lower cut‐off is used to rule out diabetes and the higher cut‐off is used to diagnose diabetes without measuring FPG and/or two‐hour postload glucose levels (2 h‐PG). In this setting, FPG and/or 2 h‐PG are only measured if the HbA1c concentration is between these two cut‐offs.[8](#edm230-bib-0008){ref-type="ref"}, [9](#edm230-bib-0009){ref-type="ref"}, [10](#edm230-bib-0010){ref-type="ref"}

Despite the advantages of HbA1c‐based diabetes screening, there is an ongoing debate about the usefulness of this marker to detect individuals with diabetes and prediabetes. A large number of studies have addressed this question in different populations, however resulting in ambiguous results and conclusions particularly with regard to optimal cut‐off values for diagnostic decisions.[11](#edm230-bib-0011){ref-type="ref"}, [12](#edm230-bib-0012){ref-type="ref"}, [13](#edm230-bib-0013){ref-type="ref"}, [14](#edm230-bib-0014){ref-type="ref"}, [15](#edm230-bib-0015){ref-type="ref"}, [16](#edm230-bib-0016){ref-type="ref"}, [17](#edm230-bib-0017){ref-type="ref"}, [18](#edm230-bib-0018){ref-type="ref"}, [19](#edm230-bib-0019){ref-type="ref"}, [20](#edm230-bib-0020){ref-type="ref"}, [21](#edm230-bib-0021){ref-type="ref"}, [22](#edm230-bib-0022){ref-type="ref"}, [23](#edm230-bib-0023){ref-type="ref"}, [24](#edm230-bib-0024){ref-type="ref"} Importantly, stepwise diabetes screening strategies using only HbA1c as first‐instance diagnostic parameter may cause failure to detect individuals with abnormal glucose regulation and possible signs of microvascular complications despite HbA1c levels below the "rule‐out" cut‐off. In this study, we analysed the diagnostic performance of HbA1c compared to FPG and 2 h‐PG in a representative sample of adult individuals taken from an urban general population, who were not yet diagnosed with diabetes. We were particularly interested in assessing the prevalence of individuals with moderately increased albuminuria among individuals considered to have a normal glucose metabolism based on HbA1c testing.

2. MATERIALS AND METHODS {#edm230-sec-0007}
========================

2.1. Study population {#edm230-sec-0008}
---------------------

The present investigation was part of the "LIFE‐Adult‐Study", a population‐based cohort study initiated in 2011. In 2014, this study has completed the cross‐sectional baseline examination of 10 000 randomly selected adults from Leipzig, a major city in Germany with approximately 580 000 inhabitants. The LIFE‐Adult‐Study is part of the "Leipzig Research Centre for Civilization Diseases" (LIFE), aiming to investigate disease prevalences, early onset markers, genetic predispositions, and the role of lifestyle factors for the development of major civilization diseases. Details of the objectives and the design of the LIFE‐Adult‐Study are described elsewhere.[25](#edm230-bib-0025){ref-type="ref"} A total of 9479 subjects were aged 40‐79 years, which was the age range of interest for our specific research question. Of these, 8243 individuals had no personal history of diabetes. Of these, a total of 2695 individuals between 40 and 79 years of age without known diabetes had complete measurements of HbA1c and fasting plasma glucose (FPG), and had also performed a 75‐g oral glucose tolerance test (OGTT) with measurement of the two‐hour postload glucose level (2 h‐PG). Moreover, the urine albumin‐creatinine ratio (UACR) was determined in these individuals.

Not all 8243 individuals had complete measurements particularly because the OGTT was performed only in a subset of individuals for reasons of feasibility and costs. There were no large differences regarding age and sex distribution between the study sample and the individuals with incomplete measurements.

The LIFE‐Adult‐Study was approved by the responsible institutional ethics committee of the Medical Faculty of the University of Leipzig. Written informed consent was obtained from all participants prior to study enrolment.

2.2. Laboratory measurements {#edm230-sec-0009}
----------------------------

The OGTT was conducted after fasting for at least 8 hours. After initial peripheral blood drawing and intake of 75 g of glucose solution (Accu‐Chek^®^ Dextrose O.G.T. Saft, Roche Diagnostics Deutschland GmbH, Mannheim, Germany), another peripheral blood sample was taken after 120 minutes for measurement of glucose concentration (2 h‐PG). All participants were also asked to provide a urine sample. The UACR was determined from morning spot urine samples. All samples were processed immediately and highly standardized in the LIFE preanalytical laboratory. Laboratory analyses were performed on the same day at the Institute of Laboratory Medicine of the University Hospital Leipzig (accredited by ISO 15189 and 17025) according to the "Quality Standards for Medical Laboratories of the German Chamber of Physicians (RiLiBÄK)". HbA1c (turbidimetric assay), creatinine (enzymatic colorimetric assay) and albumin (turbidimetric assay) were analysed using a "Cobas 8000 Clinical Chemistry Analyzer" with test kits from Roche (Roche Diagnostics GmbH).

2.3. Statistical analysis {#edm230-sec-0010}
-------------------------

Based on their HbA1c measurements, study participants were divided into three groups: "normal" (HbA1c \<5.7% \[\<39 mmol/mol\]), "prediabetes" (HbA1c between ≥5.7% to \<6.5% \[≥39 to \<48 mmol/mol\]) and "diabetes" (HbA1c ≥6.5% \[≥48 mmol/mol\]). Likewise, all individuals were also classified into three groups based on their FPG and 2 h‐PG measurements: "normal" (FPG \<5.6 mmol/L and 2 h‐PG \<7.8 mmol/L), "prediabetes" (FPG between ≥5.6 to \<7.0 mmol/L and/or 2 h‐PG between ≥7.8 and \<11.0 mmol/L), and "diabetes" (FPG ≥7.0 mmol/L or 2 h‐PG ≥11.0 mmol/L). The cut‐offs chosen for these tripartitions are in accordance with the current clinical practice recommendations of the German Diabetes Association suggesting a stepwise diagnostic procedure with HbA1c as primary diagnostic parameter.[10](#edm230-bib-0010){ref-type="ref"} This stepwise approach allows the diagnosis of diabetes to be made if HbA1c exceeds an upper cut‐off of ≥6.5% (≥48 mmol/mol), while diabetes (and prediabetes) is ruled out at a lower cut‐off of \<5.7% (\<39 mmol/mol). Only If HbA1c falls in between ≥5.7 and \<6.5% (≥39 to \<48 mmol/mol), additional measurement of FPG and/or 2 h‐PG is recommended. Participants with a urine albumin/creatinine ratio (UACR) of \>20 mg/g (men) or \>30 mg/g (women) were considered to have moderately increased albuminuria based on the clinical practice recommendations of the German Diabetes Association.[26](#edm230-bib-0026){ref-type="ref"}

Statistical comparisons between groups of individuals were performed using the *t* test (or the Mann‐Whitney *U* test where appropriate) for continuous variables, and the chi‐square test (or Fisher\'s exact test where required) for categorical variables. Receiver operating characteristic (ROC) analysis including calculation of the area under the ROC curve (ROC‐AUC) was used to quantify the performance of HbA1c to identify individuals with diabetes (or prediabetes plus diabetes) based on FPG and 2 h‐PG. Multivariate logistic regression analysis was employed to investigate whether gender, age, body mass index (BMI), and HbA1c are predictors for the presence of prediabetes (including diabetes) as judged by FPG and 2 h‐PG. Multivariate logistic regression analysis was also used to investigate the association between diabetes status according to FPG/2 h‐PG and the presence of moderately increased albuminuria adjusting for confounders such as age, gender, systolic blood pressure, high‐ and low‐density lipoprotein, and triglycerides. Two‐sided *P*‐values \<0.05 were considered statistically significant. All analyses were conducted using IBM SPSS Statistics for Windows, Version 24.0 (IBM Corporation, Armonk, NY, USA).

3. RESULTS {#edm230-sec-0011}
==========

Table [1](#edm230-tbl-0001){ref-type="table"} shows the characteristics of the study participants (n = 2695, 48% men) for those considered to have no diabetes, prediabetes, or diabetes according to the stepwise diagnostic procedure currently recommended by the German Diabetes Association. According to this algorithm, 70 (2.6%) individuals were considered to have a newly diagnosed diabetes, and 125 (4.6%) individuals were considered to have prediabetes. Individuals with diabetes were significantly more often male. On average, they were older, had a higher body mass index and waist‐to‐hip ratio, a higher systolic blood pressure, and higher levels of triglycerides and LDL cholesterol but lower levels of HDL cholesterol. There were also significant differences regarding serum urea and uric acid concentrations. The UACR was significantly increased in individuals with prediabetes and diabetes.

###### 

Characteristics of the study population (n = 2695)

                               Diabetes status According to stepwise use of HbA1c (first step) and FPG/2 h‐PG (conditional second step)   Total n = 2695 (100.0%)   *P* [a](#edm230-note-0004){ref-type="fn"}                  
  ---------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------- ------------------------------------------- -------------- -------------------
  Age (y), no. (%)                                                                                                                                                                                                             
   40‐49                       889 (35.6)                                                                                                 15 (12.0)                 9 (12.9)                                    913 (33.9)     \<0.001 (a, b)
   50‐59                       767 (30.7)                                                                                                 41 (32.8)                 23 (32.9)                                   831 (30.8)     
   60‐69                       524 (21.0)                                                                                                 35 (28.0)                 24 (34.3)                                   583 (21.6)     
   70‐79                       320 (12.8)                                                                                                 34 (27.2)                 14 (20.0)                                   368 (13.7)     
  Sex, no. (%)                                                                                                                                                                                                                 
   Male                        1188 (47.5)                                                                                                72 (57.6)                 42 (60.0)                                   1302 (48.3)    \<0.001 (a)
   Female                      1312 (52.5)                                                                                                53 (42.4)                 28 (40.0)                                   1393 (51.7)    
  BMI (kg/m^2^)                26.7 ± 4.2                                                                                                 29.5 ± 4.5                31.5 ± 6.3                                  27.0 ± 4.4     \<0.001 (a, b, c)
  WHR                          0.92 ± 0.09                                                                                                0.97 ± 0.07               1.0 ± 0.08                                  0.92 ± 0.09    \<0.001 (a, b, c)
  SBP (mm Hg)                  126.0 ± 15.7                                                                                               128.4 ± 16.1              135.8 ± 20.6                                126.4 ± 16.0   \<0.001 (b, c)
  DBP (mm Hg)                  74.9 ± 9.6                                                                                                 74.8 ± 10.2               77.8 ± 11.2                                 75.0 ± 9.7     0.055
  Triglycerides (mmol/L)       1.4 ± 1.1                                                                                                  1.6 ± 0.9                 1.8 ± 0.9                                   1.4 ± 1.1      \<0.001 (a, b)
  Total Cholesterol (mmol/L)   5.6 ± 1.0                                                                                                  5.8 ± 1.2                 5.6 ± 1.0                                   5.6 ± 1.0      0.264
  HDL (mmol/L)                 1.7 ± 0.5                                                                                                  1.5 ± 0.4                 1.4 ± 0.4                                   1.6 ± 0.5      \<0.001 (a, b)
  LDL (mmol/L)                 3.5 ± 0.9                                                                                                  3.8 ± 1.0                 3.6 ± 1.0                                   3.5 ± 0.9      0.005 (a)
  Creatinine (mmol/L)          79.9 ± 23.0                                                                                                82.1 ± 15.0               80.4 ± 18.5                                 80.0 ± 22.6    0.548
  Urea (mmol/L)                5.0 ± 1.4                                                                                                  5.4 ± 1.6                 5.1 ± 1.6                                   5.0 ± 1.4      0.003 (a)
  Uric acid (mmol/L)           313.5 ± 81.7                                                                                               348.7 ± 78.2              375.3 ± 86.8                                316.8 ± 82.5   \<0.001 (a, b, c)
  eGFR (mL/min/1.73 m^2^)      82.4 ± 14.4                                                                                                80.2 ± 13.9               84.7 ± 18.4                                 82.4 ± 14.5    0.098
  uACR (mg/g)                  13.3 ± 80.5                                                                                                26.3 ± 175.5              34.8 ± 82.8                                 14.5 ± 87.3    0.038 (b)
  HbA1c (%)                    5.2 ± 0.3                                                                                                  5.9 ± 0.2                 6.6 ± 1.6                                   5.3 ± 0.5      
  HbA1c (mmol/mol)             33.5 ± 3.2                                                                                                 40.7 ± 2.7                48.2 ± 17.3                                 34.2 ± 5.0     
  FPG (mmol/L)                 5.4 ± 0.6                                                                                                  6.1 ± 0.4                 7.7 ± 2.0                                   5.5 ± 0.8      
  2 h‐PG (mmol/L)              5.9 ± 1.7                                                                                                  7.0 ± 1.9                 12.8 ± 4.6                                  2.1 ± 0.1      

BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PG, postchallenge plasma glucose; SBP, systolic blood pressure; uACR, urine albumin‐creatinine ratio; WHR, waist‐to‐hip ratio.

Unless otherwise specified, data are shown as mean ± standard deviation.

*P*‐value represents the results of the overall comparison of the three groups (normal, prediabetes and diabetes). The letters a, b and c indicate that post hoc pairwise comparison was significant (*P* \< 0.05): a, normal vs. prediabetes; b, normal vs. diabetes; c, prediabetes vs. diabetes.

John Wiley & Sons, Ltd

Table [2](#edm230-tbl-0002){ref-type="table"} shows a comparison of the diabetes status (normal, prediabetes, diabetes) as determined by the HbA1c concentration vs. the diabetes status as determined by FPG/2 h‐PG levels. Based on HbA1c, 234 individuals (8.7%) had a prediabetic condition, and 22 individuals (0.8%) were considered to have diabetes. In contrast, the prevalence of prediabetes according to FPG/2 h‐PG was considerably higher (37%, 996 individuals), and also the prevalence of diabetes was higher (4.1%, 110 individuals). Among the 234 individuals with prediabetes according to HbA1c, 61 (26.1%) were normal according to FPG/2 h‐PG, and 48 (20.5%) were classified as having diabetes. Among 2439 individuals with normal HbA1c, 868 (35.6%) and 45 (1.8%) were considered to be prediabetic or diabetic, respectively, according to their FPG/2 h‐PG concentrations. The concordance rate between the classification based on HbA1c and FPG/2 h‐PG was 61.6%. The sensitivity and specificity of HbA1c to recognize diabetes (HbA1c ≥6.5% or ≥48 mmol/mol) according to the FPG/2 h‐PG definition was 15.5% and 99.8%, respectively. The sensitivity and specificity of HbA1c to recognize a normal status (HbA1c \<5.7% or \<39 mmol/mol) according to the FPG/2 h‐PG definition was 96.0% and 17.5%, respectively.

###### 

Comparison of the diabetes status (normal, prediabetes and diabetes) as determined by HbA1c vs. FPG/2 h‐PG

  Diabetes status according to FPG/2 h‐PG   Diabetes status according to HbA1c                              
  ----------------------------------------- ------------------------------------ ------------- ------------ --------------
  Normal                                    1526 (62.6%)                         61 (26.1%)    2 (9.1%)     1589 (59.0%)
  Prediabetes                               868 (35.6%)                          125 (53.4%)   3 (13.6%)    996 (37.0%)
  Diabetes                                  45 (1.8%)                            48 (20.5%)    17 (77.3%)   110 (4.1%)

John Wiley & Sons, Ltd

Figure [1](#edm230-fig-0001){ref-type="fig"} shows a ROC‐AUC analysis of the ability of the HbA1c levels in men and women to detect individuals with diabetes or prediabetes/diabetes according to FPG/2 h‐PG levels. For diabetes as the target category, ROC‐AUC was 0.81 (95% CI: 0.75‐0.88) in men and 0.87 (95% CI: 0.81‐0.93) in women. For prediabetes/diabetes, ROC‐AUC values were lower with 0.65 (95% CI: 0.62‐0.68) for men and 0.70 (95% CI: 0.67‐0.73) for women.

![Receiver operating characteristic (ROC) curves for detecting diabetes or prediabetes/diabetes according to FPG/2 h‐PG based on HbA1c levels in men and women](EDM2-1-e00030-g001){#edm230-fig-0001}

Eight hundred and sixty‐eight (35.6%, 95% CI: 33.7‐37.5) of the individuals with normal HbA1c levels had prediabetes and 45 individuals (1.8%, 95% CI: 1.4‐2.4) had diabetes according to FPG/2 h‐PG (Table [2](#edm230-tbl-0002){ref-type="table"}). Within the group of individuals with normal HbA1c, the overall prevalence of moderately increased albuminuria was 148/2439 (6.1%, 95% CI: 5.2‐7.1) (Table [3](#edm230-tbl-0003){ref-type="table"}). While the prevalence was 3.9% in the group with normal FPG/2 h‐PG levels, it was significantly higher among individuals with prediabetes (9.4%) and diabetes (13.3%) according to FPG/2 h‐PG (*P* \< 0.001). This difference remained significant after adjustment for confounders, such as gender, age, systolic blood pressure, LDL and HDL cholesterol, and triglycerides (*P* = 0.007). Individuals with prediabetes or diabetes according to FPG/2 h‐PG had a 1.80‐fold increased odds (95% CI: 1.25‐2.60) for moderately increased albuminuria compared to individuals with normal FPG/2 h‐PG levels in the adjusted analysis.

###### 

Prevalence of moderately increased albuminuria and UACR values by diabetes status according to HbA1c and FPG/2 h‐PG

  Diabetes status according to FPG/2 h‐PG   Diabetes status according to HbA1c                                   
  ----------------------------------------- ------------------------------------ ---------------- -------------- -----------------
  Normal                                    3.9% (60/1526)                       9.8% (6/61)      0.0% (0/2)     4.2% (66/1589)
  10.1 ± 42.3                               21.6 ± 85.8                          3.1 ± 0.8        10.5 ± 44.7    
  Prediabetes                               9.4% (82/868)                        10.4% (13/125)   0.0% (0/3)     9.5% (95/996)
  18.2 ± 122.1                              26.3 ± 175.5                         8.5 ± 5.6        19.1 ± 129.7   
  Diabetes                                  13.3% (6/45)                         25.0% (12/48)    35.3% (6/17)   21.8% (24/110)
  17.6 ± 39.1                               40.5 ± 95.4                          27.1 ± 49.2      29.1 ± 70.8    
  Total                                     6.1% (148/2439)                      13.2% (31/234)   27.3% (6/22)   6.9% (185/2695)
  13.1 ± 80.4                               28.0 ± 142.0                         22.4 ± 43.9      14.5 ± 87.3    

UACR values are shown as mean ± standard deviation.

John Wiley & Sons, Ltd

Receiver operating characteristic analysis within the subgroup of individuals who are considered not to have diabetes or prediabetes according to the currently recommended stepwise screening algorithm (ie, individuals with HbA1c levels \<5.7% \[\<39 mmol/L\]) revealed that HbA1c was still significantly able to discriminate between individuals with normal FPG/2 h‐PG levels vs. those with prediabetic or diabetic FPG/2 h‐PG levels (Figure [2](#edm230-fig-0002){ref-type="fig"}), however, with comparatively low AUC (0.63, 95% CI: 0.61‐0.66). Using multivariate logistic regression analysis, we examined whether additional and easily obtainable information such as gender, age, and BMI would improve the discrimination between the presence vs. absence of prediabetes/diabetes among individuals with normal HbA1c (Table [4](#edm230-tbl-0004){ref-type="table"}). This analysis revealed that male sex, higher age, higher BMI, and higher HbA1c levels were independently predictive and were able to improve the AUC to 0.74 (95% CI: 0.72‐0.76, Figure [2](#edm230-fig-0002){ref-type="fig"}).

![Receiver operating characteristic (ROC) curves for detecting prediabetes/diabetes (according to FPG/2 h‐PG definition) among individuals with normal HbA1c levels (\<5.7% \[\<39 mmol/mol\]). The solid curve shows the remaining discriminative performance of the HbA1c levels. The dashed line depicts the discriminative performance of the multivariate logistic regression model shown in Table [3](#edm230-tbl-0003){ref-type="table"} using information on gender, age and BMI in addition to the HbA1c level](EDM2-1-e00030-g002){#edm230-fig-0002}

###### 

Multivariate logistic regression analysis on predictors for the presence of prediabetes/diabetes among individuals with normal HbA1c

  Predictor                   OR     95% CI      *P*
  --------------------------- ------ ----------- ---------
  Men (ref: Women)            2.55   2.15‐3.03   \<0.001
  Age (per 10 y increase)     1.51   1.38‐1.64   \<0.001
  BMI (per point increase)    1.11   1.09‐1.13   \<0.001
  HbA1c (per 0.1% increase)   1.07   1.05‐1.08   \<0.001

John Wiley & Sons, Ltd

4. DISCUSSION {#edm230-sec-0012}
=============

The present population‐based cross‐sectional study involving adults between 40 and 79 years without a prior diagnosis of diabetes demonstrates a large prevalence of prediabetes (35.6%) according to fasting and/or two‐hour postload plasma glucose levels among individuals with HbA1c levels which are considered to be normal (\<5.7% \[\<39 mmol/L\]). Our study also shows that the prevalence of moderately increased albuminuria among these prediabetic individuals is significantly increased compared to individuals who had normal levels of all three parameters HbA1c, FPG and 2 h‐PG, even after adjustment for different confounders known to be associated with albuminuria. Moreover, our study suggests that the discrimination between individuals with normal FPG/2 h‐PG levels and individuals with prediabetic or diabetic FPG/2 h‐PG levels among individuals with normal HbA1c might be improved using easily obtainable information such as age, gender and body mass index.

A number of mostly cross‐sectional and also some longitudinal studies have previously investigated the diagnostic performance of HbA1c measurements compared to FPG and/or postload glucose levels in different at‐risk populations and ethnicities, with different results and conclusions regarding the usefulness of HbA1c and optimal diagnostic cut‐off values.[11](#edm230-bib-0011){ref-type="ref"}, [12](#edm230-bib-0012){ref-type="ref"}, [13](#edm230-bib-0013){ref-type="ref"}, [14](#edm230-bib-0014){ref-type="ref"}, [15](#edm230-bib-0015){ref-type="ref"}, [16](#edm230-bib-0016){ref-type="ref"}, [17](#edm230-bib-0017){ref-type="ref"}, [18](#edm230-bib-0018){ref-type="ref"}, [19](#edm230-bib-0019){ref-type="ref"}, [20](#edm230-bib-0020){ref-type="ref"}, [21](#edm230-bib-0021){ref-type="ref"}, [22](#edm230-bib-0022){ref-type="ref"}, [23](#edm230-bib-0023){ref-type="ref"}, [24](#edm230-bib-0024){ref-type="ref"} In line with our study, a number of these previous studies have also shown that a large proportion of individuals had a prediabetic condition according to their FPG/2 h‐PG levels despite normal HbA1c levels.[11](#edm230-bib-0011){ref-type="ref"}, [13](#edm230-bib-0013){ref-type="ref"}, [14](#edm230-bib-0014){ref-type="ref"}, [16](#edm230-bib-0016){ref-type="ref"}, [22](#edm230-bib-0022){ref-type="ref"}, [23](#edm230-bib-0023){ref-type="ref"} Our study results are also in agreement with previous studies that HbA1c has a considerably better performance to discriminate between individuals with diabetes and individuals not having diabetes compared to the performance to discriminate between normal individuals and individuals having prediabetes (or diabetes).[17](#edm230-bib-0017){ref-type="ref"}, [18](#edm230-bib-0018){ref-type="ref"}, [20](#edm230-bib-0020){ref-type="ref"}, [21](#edm230-bib-0021){ref-type="ref"}

Some other studies have examined the association between glucose parameters and albuminuria. Bahar et al[27](#edm230-bib-0027){ref-type="ref"} showed that the risk for prediabetic subjects with moderately increased albuminuria to develop diabetes mellitus was four times as high as for prediabetic subjects without moderately increased albuminuria. This finding underlines the need to detect individuals with moderately increased albuminuria, who are also at risk for diabetes. Suzuki et al[28](#edm230-bib-0028){ref-type="ref"} showed that the prevalence of moderately increased albuminuria was significantly higher in subjects with combined impaired fasting glucose and impaired glucose tolerance than in subjects with only impaired glucose tolerance. In line with these results, our study revealed that individuals with normal HbA1c but elevated FPG and/or 2 h‐PG levels have a significantly higher prevalence of moderately increased albuminuria than individuals with normal FPG and 2 h‐PG levels. In contrast, Huang et al[29](#edm230-bib-0029){ref-type="ref"} found that HbA1c, but not FPG or 2 h‐PG, was associated with risk of low‐grade albuminuria. The South London Diabetes Study found an increased prevalence of moderately increased albuminuria when comparing participants with T2DM according to FPG and/or 2 h‐PG and HbA1c to participants with T2DM with normal HbA1c.[30](#edm230-bib-0030){ref-type="ref"}

Our study shows that individuals with moderately increased albuminuria despite normal HbA1c escape early detection and treatment, if screening relies only on HbA1c. Our results also indicate that using clinical information such as age, gender, and BMI might be helpful to decide whom to recommend an additional measurement of FPG and/or 2 h‐PG despite normal HbA1c levels. The Canadian clinical practice guideline of the Canadian Diabetes Association, for example, did so by adding another HbA1c cut‐off and by including risk factors in the diagnostic algorithm.[9](#edm230-bib-0009){ref-type="ref"} Moreover, a number of diabetes prediction models based on clinical data have been proposed in the past, for example the Leicester Diabetes Risk Score in primary care setting particularly with regard to detection of prediabetes.[31](#edm230-bib-0031){ref-type="ref"} Further studies are needed to compare how these tools compare to the simple model based on age, gender and BMI proposed here.

Some limitations of the present study need to be addressed. First, the cross‐sectional approach does not allow proving a causal relationship between the increased FPG/2 h‐PG levels among individuals with normal HbA1c levels and the increased prevalence of moderately increased albuminuria, which would require long‐term longitudinal follow‐up studies. The first follow‐up of the LIFE‐Adult‐Study is currently under way. Second, the present analyses did not include other important early organ damages such as retinopathy. Third, there are several other causes of albuminuria apart from diabetic nephropathy, such as fever, infection, strenuous exercise within 24 hours, pregnancy and hypertension. Pregnancy was a general exclusion criterion in the LIFE‐Adult‐Study. Information on fever, infection and strenuous exercise was not collected. Therefore, an adjustment for these confounders was not possible. However, multivariate logistic regression analysis adjusting for systolic blood pressure revealed that among individuals with normal HbA1c levels the presence of moderately increased albuminuria was still significantly higher in individuals with prediabetic and diabetic levels of FPG and/or 2 h‐PG compared to individuals with normal FPG and 2 h‐PG levels. Furthermore, our study is limited to an urban and predominantly White Caucasian population in a specific eastern region of Germany. It has been shown that there are regional differences in diabetes prevalence within Germany, with higher prevalences in the eastern parts.[32](#edm230-bib-0032){ref-type="ref"} Thus, our results might not be applicable to populations with other ethnicities, since it has been shown that results may vary depending on ethnicity and race.[15](#edm230-bib-0015){ref-type="ref"} A large nationwide epidemiologic study based on a random sample of 200 000 individuals from the general population across Germany aiming to identify new and tailored strategies for early detection, prediction, and primary prevention of major diseases, including diabetes, is currently under way.[33](#edm230-bib-0033){ref-type="ref"}

In conclusion, the results of our study show an increased prevalence of moderately increased albuminuria among individuals with normal HbA1c level but impaired glucose regulation. These individuals escape detection and early treatment if only HbA1c is used for diabetes screening. Easily obtainable parameters such as age, gender and BMI might be used in addition to the HbA1c level to decide whether additional FPG and/or OGTT testing should be performed to detect individuals with impaired glucose regulation despite normal HbA1c levels.
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